Equity research analysts expect Trupanion, Inc. (NASDAQ:TRUP – Get Rating) to report earnings of ($0.20) per share for the current quarter, according to Zacks. Four analysts have made earnings estimates for Trupanion, with the lowest EPS estimate being $0.23 and the highest estimate of $0.15. Trupanion reported earnings per share of ($0.08) in the same quarter last year, indicating a negative 150% year-over-year growth rate. The company is expected to release its next quarterly results on Monday, January 1.
On average, analysts expect Trupanion to report annual earnings of ($0.77) per share for the current year, with EPS estimates ranging from ($0.91) to ($0.53 $). For the next fiscal year, analysts expect the company to report earnings of ($0.46) per share, with EPS estimates ranging from ($0.70) to $0.05. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts who provide coverage for Trupanion.
Trupanion (NASDAQ:TRUP – Get Rating) last announced its quarterly results on Thursday, April 28. The financial services provider reported ($0.22) earnings per share (EPS) for the quarter, missing analyst consensus estimates of ($0.17) by ($0.05). Trupanion had a negative return on equity of 8.66% and a negative net margin of 4.26%. The company posted revenue of $206.00 million for the quarter, compared to $202.32 million expected by analysts. During the same period last year, the company posted ($0.31) earnings per share. The company’s quarterly revenue increased 33.2% year over year.
Several equity analysts have published reports on the stock. StockNews.com assumed coverage of Trupanion shares in a Thursday, March 31 report. They put a “sell” mark on the stock. Zacks Investment Research downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a Wednesday, May 4, report. Piper Sandler cut her target price on Trupanion shares from $95.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday. TheStreet upgraded Trupanion’s shares from a “c-” to a “d+” rating in a Wednesday, April 6 research report. Finally, Lake Street Capital reduced its target price on shares of Trupanion from $150.00 to $120.00 in a Thursday, February 17 research report. One equity research analyst has assigned the stock a sell rating, one has assigned a hold rating and two have assigned the company a buy rating. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $99.60.
In other Trupanion news, COO Tricia Plouf sold 3,500 shares of Trupanion in a trade dated Thursday, March 17. The shares were sold at an average price of $85.00, for a total transaction of $297,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. Additionally, CEO Darryl Rawlings sold 4,000 shares of Trupanion in a trade dated Friday, March 11. The shares were sold at an average price of $81.04, for a total transaction of $324,160.00. The disclosure of this sale can be found here. In the past 90 days, insiders have sold 27,758 shares of the company valued at $2,228,675. 6.77% of the shares are held by insiders of the company.
Several institutional investors and hedge funds have recently changed their positions in the company. FNY Investment Advisers LLC bought a new position in shares of Trupanion in the fourth quarter worth about $28,000. Rational Advisors LLC increased its stake in shares of Trupanion by 112.5% in the fourth quarter. Rational Advisors LLC now owns 238 shares of the financial services provider valued at $31,000 after purchasing an additional 126 shares during the period. Lindbrook Capital LLC bought a new stock position in Trupanion in the fourth quarter worth about $36,000. Prospera Financial Services Inc bought a new position in shares of Trupanion in the first quarter worth approximately $49,000. Finally, Tcwp LLC bought a new position in shares of Trupanion in the first quarter worth approximately $54,000. Institutional investors and hedge funds own 83.62% of the company’s shares.
NASDAQ TRUP shares opened at $68.96 on Friday. The company’s fifty-day moving average price is $75.85 and its 200-day moving average price is $96.17. Trupanion has a 1-year low of $54.68 and a 1-year high of $158.25. The company has a market capitalization of $2.81 billion, a PE ratio of -87.29 and a beta of 2.15. The company has a debt ratio of 0.16, a quick ratio of 1.88 and a current ratio of 1.88.
About Trupanion (Get an evaluation)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico and Australia. The Company operates in two segments, subscription business and other business. It serves pet owners and veterinarians.
Get a Free Copy of Zacks Research Report on Trupanion (TRUP)
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Trupanion right now?
Before you consider Trupanion, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Trupanion wasn’t on the list.
Although Trupanion currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here